ORIGINAL PAPER
The impact of the COVID-19 pandemic on the incidence and clinical course of acute post-streptococcal glomerulonephritis in children – single-centre experience
1
Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
2
Department of Paediatric Nephrology with Dialysis Division for Children, Independent Public Clinical Hospital No. 1, Zabrze, Poland
3
Department of Rehabilitation, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
These authors had equal contribution to this work
Submission date: 2024-07-04
Final revision date: 2024-07-19
Acceptance date: 2024-07-26
Publication date: 2024-09-30
Corresponding author
Artur Janek
Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Pediatr Pol 2024;99(3):211-217
KEYWORDS
acute post-streptococcal glomerulonephritis (APSGN)Group A Streptococcuspost-pandemic COVID-19 infections
TOPICS
ABSTRACT
Introduction::
During the SARS-CoV-2 pandemic, a decrease in acute post-streptococcal glomerulonephritis (APSGN) cases was observed; however, as the pandemic subsided, reports of an increased number of diagnosed APSGN cases in the paediatric population emerged. The aim of our study was to compare the number of cases and the patient profile diagnosed with acute post-streptococcal glomerulonephritis in our centre before and after the COVID-19 pandemic.
Material and methods::
A retrospective study included 47 patients (21 females, 26 males) diagnosed with APSGN, hospitalised in our centre between 2013–2023. The parameters were compared between the group of patients diagnosed before and after the pandemic. Age at day of diagnosis, history of previous possible streptococcal infection, antistreptolysin O (ASO), C3, epidermal growth factor receptor levels at admission, the presence of the features of nephritic syndrome, the need for pharmacological treatment, and renal replacement therapy were analysed. Additionally, anthropometric measurements the C4 complement component were determined.
Results::
From 2013 to 2022, the average number of diagnosed APSGN cases per year was 3.67, increasing to 7 cases per year since 2022. A statistically significant difference in ASO level values at admission was observed between patients diagnosed with post-streptococcal glomerulonephritis before the pandemic (767 IU/ml) compared to those diagnosed after the pandemic (1362 IU/ml). No other statistically significant differences were found in the patient profile analysis.
Conclusions::
During the COVID-19 pandemic, no cases of APSGN were observed in our centre, probably due to the implemented personal protective measures and population isolation. After the COVID-19 pandemic, there was an increase in APSGN cases among children. The patient profile with diagnosis before and after the pandemic in terms of most parameters does not differ. The only significant difference was observed in ASO levels, which were higher in patients diagnosed after the pandemic compared to those diagnosed before the pandemic. Further research is needed.
During the SARS-CoV-2 pandemic, a decrease in acute post-streptococcal glomerulonephritis (APSGN) cases was observed; however, as the pandemic subsided, reports of an increased number of diagnosed APSGN cases in the paediatric population emerged. The aim of our study was to compare the number of cases and the patient profile diagnosed with acute post-streptococcal glomerulonephritis in our centre before and after the COVID-19 pandemic.
Material and methods::
A retrospective study included 47 patients (21 females, 26 males) diagnosed with APSGN, hospitalised in our centre between 2013–2023. The parameters were compared between the group of patients diagnosed before and after the pandemic. Age at day of diagnosis, history of previous possible streptococcal infection, antistreptolysin O (ASO), C3, epidermal growth factor receptor levels at admission, the presence of the features of nephritic syndrome, the need for pharmacological treatment, and renal replacement therapy were analysed. Additionally, anthropometric measurements the C4 complement component were determined.
Results::
From 2013 to 2022, the average number of diagnosed APSGN cases per year was 3.67, increasing to 7 cases per year since 2022. A statistically significant difference in ASO level values at admission was observed between patients diagnosed with post-streptococcal glomerulonephritis before the pandemic (767 IU/ml) compared to those diagnosed after the pandemic (1362 IU/ml). No other statistically significant differences were found in the patient profile analysis.
Conclusions::
During the COVID-19 pandemic, no cases of APSGN were observed in our centre, probably due to the implemented personal protective measures and population isolation. After the COVID-19 pandemic, there was an increase in APSGN cases among children. The patient profile with diagnosis before and after the pandemic in terms of most parameters does not differ. The only significant difference was observed in ASO levels, which were higher in patients diagnosed after the pandemic compared to those diagnosed before the pandemic. Further research is needed.
REFERENCES (23)
1.
Fadl AA, Aldubaib HSH, Alzayyat NTF, et al. Overview on acute poststreptococcal glomerulonephritis in pediatrics: a review. J Pharm Res Int 2021; 33: 34-39.
2.
Stoian M, Scarlat G, Dona B, et al. Clinico-pathological correlations of poststreptococcal glomerulonephritis. Intern Med 2022; 19: 63-70.
3.
Skrzypczyk P, Ofiara A, Zacharzewska A, et al. Acute post-streptococcal glomerulonephritis – immune-mediated acute kidney injury – case report and literature review. Cent Eur J Immunol 2021; 46: 516-523.
4.
Oda T, Yoshizawa N. Factors affecting the progression of infectionrelated glomerulonephritis to chronic kidney disease. Int J Mol Sci 2021; 22: 905.
5.
Miller KM, van Beneden C, McDonald M, et al. Epidemiological surveillance of acute poststreptococcal glomerulonephritis. Open Forum Infect Dis 2022; 9: 57-64.
6.
Bateman E, Mansour S, Okafor E, et al. Examining the efficacy of antimicrobial therapy in preventing the development of postinfectious glomerulonephritis: a systematic review and meta-analysis. Infect Dis Rep 2022; 14: 176-183.
7.
Rawla P, Padala SA, Ludhwani D. Poststreptococcal glomerulonephritis. Available from: https://www.ncbi.nlm.nih.gov/b... (accessed: 09.10.2022).
8.
Ong LT. Management and outcomes of acute post-streptococcal glomerulonephritis in children. World J Nephrol 2022; 11: 139-145.
9.
Alhamoud MA, Salloot IZ, Mohiuddin SS, et al. A comprehensive review study on glomerulonephritis associated with poststreptococcal infection. Cureus 2021; 13: e20212.
10.
Rodriguez-Iturbe B, Haas M. Post-streptococcal glomerulonephritis. In: Ferretti JJ, Stevens DL, Fischetti VA (eds.). Streptococcus pyogenes: basic biology to clinical manifestations [Internet]. University of Oklahoma Health Sciences Center, Oklahoma City (OK) 2016.
11.
Xu H, Somers MJG. Acute post-streptococcal glomerulonephritis, In: Emma F, Goldstein SL, Bagga A, Bates CM, Shroff R (eds.). Pediatric nephrology. 8th ed. Springer Nature, Switzerland AG 2022, 660-671.
12.
Majeed HA, Yousof AM, Rotta J, et al. Group A streptococcal strains in Kuwait: a nine-year prospective study of prevalence and associations. Pediatr Infect Dis J 1992; 11: 295-300.
13.
Woo KT, Chan CM, Lim C, et al. A global evolutionary trend of the frequency of primary glomerulonephritis over the past four decades. Kidney Dis (Basel) 2019; 5: 247-258.
14.
Brueggemann AB, Jansen van Rensburg MJ, Shaw D. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health 2021; 3: e360-e370.
15.
Marchetti, F. La recrudescenza delle infezioni (anche) da streptococco beta-emolitico di gruppo A? Medico Bambino 2023; 42: 45-47.
16.
Richards VP, Palmer SR, Pavinski Bitar PD. Phylogenomics and the dynamic genome evolution of the genus Streptococcus. Genome Biol Evol 2014; 6: 741-53.
17.
Serrano Viñuales I, Ruiz Del Olmo Izuzquiza I, Romero Salas Y, et al. Glomerulonefritis rápidamente progresiva de etiología posinfecciosa. Caso pediátrico [Postinfectious rapidly progressive glomerulonephritis in a pediatric patient]. Arch Argent Pediatr 2019; 117: e363-e367.
18.
Schwartz GJ, Haycock GB, Edelmann CM Jr, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
19.
Iyengar A, Kamath N, Radhakrishnan J, et al. Infection-related glomerulonephritis in children and adults. Semin Nephrol 2024; 19: 151469.
20.
Principi N, Autore G, Ramundo G, et al. Epidemiology of respiratory infections during the COVID-19 Pandemic. Viruses 2023; 15: 1160.
21.
Van Kempen EB, Bruijning-Verhagen PCJ, Borensztajn D, et al. Increase in invasive Group a Streptococcal Infections in children in the Netherlands, a survey among 7 hospitals in 2022. Pediatr Infect Dis J 2023; 42: e122-e124.
22.
Abo YN, Oliver J, McMinn A, et al. Increase in invasive group A Streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac 2023; 41: 100873.
23.
World Health Organization. Increased incidence of scarlet fever and invasive Group A Streptococcus Infection – multi-country. Available from: https://www.who.int/emergencie....
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
